Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers

被引:30
作者
Castellani, C
Picci, L
Scarpa, M
Dechecchi, MC
Zanolla, L
Assael, BM
Zacchello, F
机构
[1] Osped Civile, Cyst Fibrosis Ctr, Azienda Osped Verona, I-37126 Verona, Italy
[2] Univ Padua, Dept Pediat, Padua, Italy
[3] Univ Verona, Dept Cardiol, Verona, Italy
关键词
immunoreactive trypsinogen; neonatal; screening; CF heterozygotes;
D O I
10.1002/ajmg.a.30470
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Following cystic fibrosis (CF) neonatal screening implementation, a high frequency of heterozygotes has been reported among neonates with elevated immunoreactive trypsinogen (IRT) and normal sweat chloride levels. We studied the relationship between normal IRT values and CF heterozygosity: 10,000 neonates were screened for CF by IRT measurement and tested for 40 CF mutations; the 294 carriers detected were coupled with newborns negative to the same genetic testing, and the two groups' IRT levels compared. Heterozygotes had higher IRT levels than their controls (mean 35.32 vs. 27.58 mu g/L, P < 0.001). Even within normal trypsinogen range, the probability of being a CF carrier increases with neonatal IRT concentration. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:142 / 144
页数:3
相关论文
共 11 条
[1]   Many ΔF508 heterozygote neonates with transient hypertrypsinaemia have a second, mild CFTR mutation [J].
Boyne, J ;
Evans, S ;
Pollitt, RJ ;
Taylor, CJ ;
Dalton, A .
JOURNAL OF MEDICAL GENETICS, 2000, 37 (07) :543-547
[2]   CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test [J].
Castellani, C ;
Bonizzato, A ;
Mastella, G .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (04) :297-301
[3]   A pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes [J].
Castellani, C ;
Quinzii, C ;
Altieri, S ;
Mastella, G ;
Assael, BM .
GENETIC TESTING, 2001, 5 (03) :249-254
[4]   Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in neonatal hypertrypsinaemia with normal sweat test [J].
Castellani, C ;
Benetazzo, MG ;
Tamanini, A ;
Begnini, A ;
Mastella, G ;
Pignatti, PF .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (03) :202-205
[5]  
DANKERTROELSE JE, 1994, CYSTIC FIBROSIS CURR, P303
[6]   THE MEANING AND USE OF THE AREA UNDER A RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE [J].
HANLEY, JA ;
MCNEIL, BJ .
RADIOLOGY, 1982, 143 (01) :29-36
[7]   ABNORMAL FREQUENCY OF DELTA-F(508) MUTATION IN NEONATAL TRANSITORY HYPERTRYPSINAEMIA [J].
LAROCHE, D ;
TRAVERT, G .
LANCET, 1991, 337 (8732) :55-55
[8]   Blood immunoreactive trypsinogen concentrations are genetically determined in healthy and cystic fibrosis newborns [J].
Lecoq, I ;
Brouard, J ;
Laroche, D ;
Férec, C ;
Travert, G .
ACTA PAEDIATRICA, 1999, 88 (03) :338-341
[9]   Pancreatic function and extended mutation analysis in ΔF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels [J].
Massie, RJ ;
Wilcken, B ;
Van Asperen, P ;
Dorney, S ;
Gruca, M ;
Wiley, V ;
Gaskin, K .
JOURNAL OF PEDIATRICS, 2000, 137 (02) :214-220
[10]   Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis [J].
Scotet, V ;
De Braekeleer, M ;
Audrézet, MP ;
Lodé, L ;
Verlingue, C ;
Quéré, I ;
Mercier, B ;
Duguépéroux, I ;
Codet, JP ;
Moineau, MP ;
Parent, P ;
Férec, C .
CLINICAL GENETICS, 2001, 59 (01) :42-47